Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Changes in Stockholders' Equity (Unaudited)

v3.20.2
Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Cumulative Effect Period of Adoption Adjustment
Cumulative Effect Period of Adoption Adjusted Balance
Common Stock - Number of Shares, Shares Issued
Common Stock - Number of Shares, Shares Issued
Cumulative Effect Period of Adoption Adjusted Balance
Common Stock - Number of Shares, Treasury Shares
Common Stock - Number of Shares, Treasury Shares
Cumulative Effect Period of Adoption Adjusted Balance
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect Period of Adoption Adjusted Balance
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect Period of Adoption Adjusted Balance
Retained Earnings
Retained Earnings
Cumulative Effect Period of Adoption Adjustment
Retained Earnings
Cumulative Effect Period of Adoption Adjusted Balance
Balance at beginning of period at Dec. 31, 2018 $ 552,568     $ 33   $ (108,637)   $ 569,712   $ (6,079)   $ 97,539    
Beginning balance, shares issued (shares) at Dec. 31, 2018       33,202,369                    
Beginning balance, treasury stock (shares) at Dec. 31, 2018           (2,273,932)                
Beginning balance, shares outstanding (shares) at Dec. 31, 2018       30,928,437                    
Stock options exercised 22             22            
Stock options exercised (shares)       1,900                    
Restricted stock awards, net of forfeitures (shares)       67,563                    
Share-based compensation expense 1,371             1,371            
Restricted stock surrendered due to employee tax liability (439)         $ (439)                
Restricted stock surrendered due to employee tax liability (shares)       (22,737)   (22,737)                
Cash dividends declared (common stock, $0.24/share, $0.12/share, $0.48/share, $0.36/share) (14,846)                     (14,846)    
Net income 17,328                     17,328    
Change in unrealized gain (loss) on securities available for sale, net of income taxes 8,454                 8,454        
Balance at end of period at Jun. 30, 2019 564,458     $ 33   $ (109,076)   571,105   2,375   100,021    
Ending balance, shares issued (shares) at Jun. 30, 2019       33,271,832                    
Ending balance, treasury stock (shares) at Jun. 30, 2019           (2,296,669)                
Ending balance, shares outstanding (shares) at Jun. 30, 2019       30,975,163                    
Balance at beginning of period at Mar. 31, 2019 564,292     $ 33   $ (109,062)   570,432   (1,882)   104,771    
Beginning balance, shares issued (shares) at Mar. 31, 2019       33,153,888                    
Beginning balance, treasury stock (shares) at Mar. 31, 2019           (2,293,355)                
Beginning balance, shares outstanding (shares) at Mar. 31, 2019       30,860,533                    
Stock options exercised 13             13            
Stock options exercised (shares)       1,250                    
Restricted stock awards, net of forfeitures (shares)       116,694                    
Share-based compensation expense 660             660            
Restricted stock surrendered due to employee tax liability (14)         $ (14)                
Restricted stock surrendered due to employee tax liability (shares)       (3,314)   (3,314)                
Cash dividends declared (common stock, $0.24/share, $0.12/share, $0.48/share, $0.36/share) (7,406)                     (7,406)    
Net income 2,656                     2,656    
Change in unrealized gain (loss) on securities available for sale, net of income taxes 4,257                 4,257        
Balance at end of period at Jun. 30, 2019 564,458     $ 33   $ (109,076)   571,105   2,375   100,021    
Ending balance, shares issued (shares) at Jun. 30, 2019       33,271,832                    
Ending balance, treasury stock (shares) at Jun. 30, 2019           (2,296,669)                
Ending balance, shares outstanding (shares) at Jun. 30, 2019       30,975,163                    
Balance at beginning of period at Dec. 31, 2019 $ 563,267 $ (12,167)   $ 33   $ (116,515)   $ 575,816   $ 3,382   $ 100,551 $ (12,167)  
Beginning balance, shares issued (shares) at Dec. 31, 2019       33,475,402 33,475,402                  
Beginning balance, treasury stock (shares) at Dec. 31, 2019 (2,675,778)         (2,675,778) (2,675,778)              
Beginning balance, shares outstanding (shares) at Dec. 31, 2019       30,799,624 30,799,624                  
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201613Member     us-gaap:AccountingStandardsUpdate201613Member   us-gaap:AccountingStandardsUpdate201613Member   us-gaap:AccountingStandardsUpdate201613Member   us-gaap:AccountingStandardsUpdate201613Member   us-gaap:AccountingStandardsUpdate201613Member    
Adjusted balance at Dec. 31, 2019     $ 551,101   $ 33   $ (116,515)   $ 575,816   $ 3,382     $ 88,385
Restricted stock awards, net of forfeitures (shares)       20,511                    
Share-based compensation expense $ 1,395             $ 1,395            
Restricted stock surrendered due to employee tax liability (291)         $ (291)                
Restricted stock surrendered due to employee tax liability (shares)       (27,106)   (27,106)                
Repurchase of common stock (2,196)         $ (2,196)                
Repurchase of common stock (shares)       (135,400)   (135,400)                
Cash dividends declared (common stock, $0.24/share, $0.12/share, $0.48/share, $0.36/share) (11,052)                     $ (11,052)    
Net income 11,526                     11,526    
Change in unrealized gain (loss) on securities available for sale, net of income taxes (3,047)                 $ (3,047)        
Balance at end of period at Jun. 30, 2020 $ 547,436     $ 33   $ (119,002)   577,211   335   88,859    
Ending balance, shares issued (shares) at Jun. 30, 2020       33,495,913                    
Ending balance, treasury stock (shares) at Jun. 30, 2020 (2,838,284)         (2,838,284)                
Ending balance, shares outstanding (shares) at Jun. 30, 2020       30,657,629                    
Balance at beginning of period at Mar. 31, 2020 $ 552,958     $ 33   $ (118,882)   576,585   11,867   83,355    
Beginning balance, shares issued (shares) at Mar. 31, 2020       33,448,214                    
Beginning balance, treasury stock (shares) at Mar. 31, 2020           (2,825,473)                
Beginning balance, shares outstanding (shares) at Mar. 31, 2020       30,622,741                    
Restricted stock awards, net of forfeitures (shares)       47,699                    
Share-based compensation expense 626             626            
Restricted stock surrendered due to employee tax liability (120)         $ (120)                
Restricted stock surrendered due to employee tax liability (shares)       (12,811)   (12,811)                
Cash dividends declared (common stock, $0.24/share, $0.12/share, $0.48/share, $0.36/share) (3,671)                     (3,671)    
Net income 9,175                     9,175    
Change in unrealized gain (loss) on securities available for sale, net of income taxes (11,532)                 (11,532)        
Balance at end of period at Jun. 30, 2020 $ 547,436     $ 33   $ (119,002)   $ 577,211   $ 335   $ 88,859    
Ending balance, shares issued (shares) at Jun. 30, 2020       33,495,913                    
Ending balance, treasury stock (shares) at Jun. 30, 2020 (2,838,284)         (2,838,284)                
Ending balance, shares outstanding (shares) at Jun. 30, 2020       30,657,629